RE:RE:RE:RE:RE:RE:RE:RE:RE:January 9th warrantsI may be one of the few voices here who don't like these warrant extensions. As opposed to being shareholder friendly, it could also be an indicator of potential delays and a lack of confidence in their own projected timelines. The tendency to ascribe only positive reasons for anything that smells fishy was a regular feature in my other Canadian investment that tanked. Every delay was met with a hopeful cheer and a litany of reasons why it could be a good thing. Each exec hired -or leaving - was explained away as decisions made by wise men and women who knew what they were doing. FDA submission was always around the corner, till it was not. Self-styled message board gurus churned out endless "data" and history lessons to convince everyone. Always used to wonder why medical devices analysts never covered that company. So excuse me for being a show-me skeptic. I hold quite a bit of shares and I believe in the technology and the possibilities pointed out by many. My fear is always poor execution and decisions that either cause constant delays or dilute share price. And the massive hole in awareness of this company. I hope the next announcement is not another round of selling shares and warrants to raise money. I want to see the clinical data submission as an NR. Was supposed to happen in Q4.